Tag: MedGenome
MedGenome partners with Darshan GIVA Foundation to revolutionize TB diagnosis using...
The partnership aims at an access intervention pilot for offering Whole Genome Sequencing (WGS) testing free of cost to pre diagnosed Drug-resistant TB (DRTB) patients
BioVoice eMagazine March & April 2024 | Issue 2 | Volume...
Cover story tracks the journey of MedGenome, the India’s leading genomics solutions company. Startup Special features MyHealthcare App; Expert Insights by Dr Kausik Maiti, Parexel India; Ankit Kumar, Skye Air; Dr Sat Kumar Tomer, Satyukt Analytics; and Ritwik Bahuguna, Farlense Group
Genetic testing companies can help achieve ICMR’s call for developing drugs...
Through the analysis of individuals’ genetic information, these companies uncover disease-associated genetic variations, enabling pharmaceutical firms to look beyond the conventional barriers
MedGenome appoints Martin Dewhurst as Chairman of Advisory Board
Martin will work closely with MedGenome’s Research services team in the US to build strong connects with the global life sciences community
Medgenome acquires Prognosis Laboratories
Strategic acquisition to accelerate MedGenome’s growth and geographic penetration
FACE TO FACE: Mahesh Pratapneni, Co-founder & Group CEO, MedGenome
In a highly informative conversation with Rahul Koul, Chief Editor, BioVoice News, the Co-founder & Group CEO of MedGenome, Mahesh Pratapneni, demystifies the concept of...
Dr Amit Kakar joins MedGenome Board of Directors
The company has also added Navjeewan Khosla from Novo Holdings as Board Observer. It had announced a $50 million Series D investment led by Novo Holdings in August 2022
MedGenome Labs now offering clonoSEQ® Assay in India
clonoSEQ is the 1st U. S. Food and Drug Administration (FDA) cleared MRD test for Multiple Myeloma, Chronic Lymphoblastic Leukaemia (CLL), and B-Acute Lymphoblastic Leukaemia (B-ALL)
MedGenome’s novel software to detect genetic variants for rare diseases &...
The software claims to accurately predict and rank a pathogenic variant in 90% of rare diseases cases with no or minimum manual intervention
MedGenome announces leadership transitions: Mahesh Pratapneni new Group CEO & Felix...
Co‐Founder Sam Santhosh steps down as Chairman and Group CEO; will remain on Board of Directors